About: Bladder-sparing therapy for muscle-infiltrating bladder cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Bladder-sparing therapy for muscle-infiltrating bladder cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 17 June 2008

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2008 (ast) наукова стаття, опублікована в червні 2008 (uk) مقالة علمية نشرت في 17 يونيو 2008 (ar) scientific article published on 17 June 2008 (en)
publication date	wds:Q37193611-EF91EF06-0774-4D42-8670-0383CE3ABAA9
publication date	2008-06-17 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37193611-62DCD3B7-A5A2-41FC-9670-F28E138AFD3C
language of work or name	English
exact match	wds:Q37193611-A973D0C4-A53E-4EC1-85AD-DF0C8128910D
exact match	https://scigraph.springernature.com/pub.10.1038/ncpuro1145
cites work	wds:Q37193611-01F96FF4-B0F0-49D6-A0E6-0ECB7F69DEA1 wds:Q37193611-04978B1D-6084-4871-97AA-EBA42C9DF49A wds:Q37193611-0AF08181-8D7B-47EC-B1AE-0F0BF0A882EA wds:Q37193611-0F3B73F2-1F00-4027-825C-846FBE5B8998 wds:Q37193611-2E185269-1174-4280-8C6F-96AC1440E250 wds:Q37193611-33C5D4AC-B651-41EF-8CA0-49C2F3215C94 wds:Q37193611-37E47E35-53B2-44C3-8984-4325E7729EC9 wds:Q37193611-39086233-2E38-4D39-9C9C-3C95B5893793 wds:Q37193611-3F8C2E8F-2AF0-4AB7-B0C3-7A3C77DDB839 wds:Q37193611-424A1AAE-D01D-4AD1-87F4-FDFCAA422B39 wds:Q37193611-43A36749-7791-4E6B-AC04-D901DC5C313D wds:Q37193611-4840D6F7-364B-4027-8014-133B50F1EEA0 wds:Q37193611-503BE1DC-7B30-403E-ADD8-D76984781460 wds:Q37193611-55DC1A47-1B7E-43BA-870D-7441FDDCAA6B wds:Q37193611-56146E95-E9A2-44D6-AD46-9689E29FF04E wds:Q37193611-6B1A2CE6-C398-4594-B678-5F71034DE6AB wds:Q37193611-6E9A9CE1-30AF-455B-A39F-ABC2F1837756 wds:Q37193611-6FEB6AA6-FF70-4241-91BB-97EB6EE38618 wds:Q37193611-71133359-AA15-4931-AC4C-89601D68A334 wds:Q37193611-76FF2DB0-4CC0-40D6-BA16-33085D6D7BD0 wds:Q37193611-78E12865-6F0E-44B6-B08D-E4EC97E81F5E wds:Q37193611-7981AE23-7C91-4FB1-9F8F-466641562ECE wds:Q37193611-832AB174-1321-4477-90EB-98FFA1014666 wds:Q37193611-863103C8-80B3-421E-BF62-5C00E871E66A wds:Q37193611-87BB2A69-E451-437F-A7C7-F804AE7F8A15 wds:Q37193611-89C9BEC6-17DC-445C-94A3-732B196E794E wds:Q37193611-ACFB4597-519F-4CC1-9D4A-391C318CF2B4 wds:Q37193611-ADBE4C03-11E0-41F5-BBA2-4E51B4123CEE wds:Q37193611-C69F3A11-7D1A-47F8-9954-B66F0C6F66BE wds:Q37193611-CEB22DF8-5351-45D8-895D-C7937324CBD2 wds:Q37193611-D182C192-DE2E-4FCC-96C4-DF4D07526B62 wds:Q37193611-D656817B-B6AF-460A-8349-A1030CDCB76B wds:Q37193611-DEC488F1-5667-4251-A58A-EB721441E64F wds:Q37193611-EBA1B3EF-FD84-4ECC-A98B-70C7CC7CBF12 wds:Q37193611-F2FF1C96-5EA0-4293-B488-249B59B0C5F8 wds:Q37193611-F79C9E5B-5341-4B81-B4E3-CD2269325173 wds:Q37193611-FAEAB3FF-5D4D-47E9-B5F0-DC3A0BD4086B
cites work	Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder my oncle Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12 Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. A single-institution phase II study Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. Delaying Radical Cystectomy for Muscle Invasive Bladder Cancer Results in Worse Pathological Stage Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience Can patient selection for bladder preservation be based on response to chemotherapy? Bladder preservation by combined modality therapy for invasive bladder cancer. Transurethral resection of muscle-invasive bladder cancer: 10-year outcome Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results Selective bladder preservation for muscle-invasive transitional cell carcinoma of the urinary bladder Clinical outcome of a large-scale multi-institutional retrospective study for locally advanced bladder cancer: a survey including 1131 patients treated during 1990-2000 in Japan. Feasibility of transurethral resection for muscle infiltrating carcinoma of the bladder: long-term followup of a prospective study Radical transurethral resection and chemotherapy in the treatment of muscle-invasive bladder cancer: a long-term follow-up Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome Complications and results after cystectomy in male and female patients with locally invasive bladder cancer. Chemoradiotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing program. Invasive bladder cancer: our experience with bladder sparing approach Muscle invasive bladder cancer treated by transurethral resection, followed by external beam radiation and interstitial iridium-192. Concomitant radiotherapy and carboplatin in locally advanced bladder cancer Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer Radiotherapy alone or radiochemotherapy with platin derivatives following transurethral resection of the bladder. Organ preservation and survival after treatment of bladder cancer A population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer Survival after bladder-preservation with brachytherapy versus radical cystectomy; a single institution experience Bladder-conserving surgery and interstitial brachytherapy for lymph node negative transitional cell carcinoma of the urinary bladder: results of a 28-year single institution experience The fate of patients with locally advanced bladder cancer treated conservatively with neoadjuvant chemotherapy, extensive transurethral resection and radiotherapy: 10-year experience Primary methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and bladder preservation in locally invasive bladder cancer: a 5-year followup Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy Primary cisplatin, methotrexate and vinblastine aiming at bladder preservation in invasive bladder cancer: multivariate analysis on prognostic factors Prognostic factors in invasive bladder carcinoma treated by combined modality protocol (organ-sparing approach) Rapidly alternating chemotherapy and radiotherapy instead of cystectomy for the treatment of muscle-invasive carcinoma of the urinary bladder: long term results of a pilot study
author name string	wds:Q37193611-56066832-EC2E-4EAE-B878-6E1E8DAE544C wds:Q37193611-83615882-7C3D-41E4-A512-D24309485103
author name string	Vito Pansadoro

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software